Single User License
INR 134980
Site License
INR 269960
Corporate User License
INR 404940

Service Tax Additional

select a format
Price

Single User License
USD 2000
Site License
USD 4000
Corporate User License
USD 6000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Typhoid Fever-Pipeline Review, H2 2015

Typhoid Fever-Pipeline Review, H2 2015


  Request for Sample Report

Executive Summary

Typhoid Fever-Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Typhoid Fever-Pipeline Review, H2 2015', provides an overview of the Typhoid Fever's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Typhoid Fever and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Typhoid Fever

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Typhoid Fever and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Typhoid Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Typhoid Fever pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Typhoid Fever

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Typhoid Fever pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Typhoid Fever Overview 7

Therapeutics Development 8

Pipeline Products for Typhoid Fever-Overview 8

Pipeline Products for Typhoid Fever-Comparative Analysis 9

Typhoid Fever-Therapeutics under Development by Companies 10

Typhoid Fever-Therapeutics under Investigation by Universities/Institutes 11

Typhoid Fever-Pipeline Products Glance 12

Clinical Stage Products 12

Early Stage Products 13

Unknown Stage Products 14

Typhoid Fever-Products under Development by Companies 15

Typhoid Fever-Products under Investigation by Universities/Institutes 16

Typhoid Fever-Companies Involved in Therapeutics Development 17

Chongqing Zhifei Biological Products Co., Ltd. 17

GlaxoSmithKline Plc 18

Prokarium Limited 19

Protein Potential, LLC 20

Shantha Biotechnics Limited 21

USV Limited 22

Zydus Cadila Healthcare Limited 23

Typhoid Fever-Therapeutics Assessment 24

Assessment by Monotherapy Products 24

Assessment by Combination Products 25

Assessment by Target 26

Assessment by Route of Administration 28

Assessment by Molecule Type 29

Drug Profiles 31

(typhoid fever + shigellosis) multivalent vaccine-Drug Profile 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Typhella-Drug Profile 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Typhetec-Drug Profile 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

typhoid + paratyphoid (bivalent) vaccine-Drug Profile 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

typhoid + paratyphoid vaccine-Drug Profile 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

typhoid + pneumococcal vaccine-Drug Profile 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

typhoid and paratyphoid fever vaccine-Drug Profile 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

typhoid fever polysaccharide vaccine-Drug Profile 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

typhoid vaccine-Drug Profile 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

ViCRM-197-Drug Profile 41

Product Description 41

Mechanism of Action 41

R&D Progress 41

Typhoid Fever-Recent Pipeline Updates 42

Typhoid Fever-Dormant Projects 43

Typhoid Fever-Discontinued Products 44

Typhoid Fever-Product Development Milestones 45

Featured News & Press Releases 45

Mar 11, 2013: Prokarium And University Of Birmingham Receive 0.4m Grant To Develop Next Generation Vaccines 45

Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate 45

Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine 46

Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine 46

Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study 46

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

Number of Products under Development for Typhoid Fever, H2 2015 8

Number of Products under Development for Typhoid Fever-Comparative Analysis, H2 2015 9

Number of Products under Development by Companies, H2 2015 10

Number of Products under Investigation by Universities/Institutes, H2 2015 11

Comparative Analysis by Clinical Stage Development, H2 2015 12

Comparative Analysis by Early Stage Development, H2 2015 13

Comparative Analysis by Unknown Stage Development, H2 2015 14

Products under Development by Companies, H2 2015 15

Products under Investigation by Universities/Institutes, H2 2015 16

Typhoid Fever-Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2015 17

Typhoid Fever-Pipeline by GlaxoSmithKline Plc, H2 2015 18

Typhoid Fever-Pipeline by Prokarium Limited, H2 2015 19

Typhoid Fever-Pipeline by Protein Potential, LLC, H2 2015 20

Typhoid Fever-Pipeline by Shantha Biotechnics Limited, H2 2015 21

Typhoid Fever-Pipeline by USV Limited, H2 2015 22

Typhoid Fever-Pipeline by Zydus Cadila Healthcare Limited, H2 2015 23

Assessment by Monotherapy Products, H2 2015 24

Assessment by Combination Products, H2 2015 25

Number of Products by Stage and Target, H2 2015 27

Number of Products by Stage and Route of Administration, H2 2015 28

Number of Products by Stage and Molecule Type, H2 2015 30

Typhoid Fever Therapeutics-Recent Pipeline Updates, H2 2015 42

Typhoid Fever-Dormant Projects, H2 2015 43

Typhoid Fever-Discontinued Products, H2 2015 44

List of Figures

Number of Products under Development for Typhoid Fever, H2 2015 8

Number of Products under Development for Typhoid Fever-Comparative Analysis, H2 2015 9

Number of Products under Development by Companies, H2 2015 10

Comparative Analysis by Early Stage Products, H2 2015 13

Assessment by Monotherapy Products, H2 2015 24

Assessment by Combination Products, H2 2015 25

Number of Products by Top 10 Targets, H2 2015 26

Number of Products by Stage and Top 10 Targets, H2 2015 26

Number of Products by Stage and Top 10 Routes of Administration, H2 2015 28

Number of Products by Top 10 Molecule Types, H2 2015 29

Number of Products by Stage and Top 10 Molecule Types, H2 2015 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Chongqing Zhifei Biological Products Co., Ltd.

GlaxoSmithKline Plc

Prokarium Limited

Protein Potential, LLC

Shantha Biotechnics Limited

USV Limited

Zydus Cadila Healthcare Limited

Typhoid Fever Therapeutic Products under Development, Key Players in Typhoid Fever Therapeutics, Typhoid Fever Pipeline Overview, Typhoid Fever Pipeline, Typhoid Fever Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com